327 related articles for article (PubMed ID: 7566580)
1. Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Caravaca F; Cubero JJ; Jimenez F; López JM; Aparicio A; Cid MC; Pizarro JL; Liso J; Santos I
Nephrol Dial Transplant; 1995; 10(5):665-70. PubMed ID: 7566580
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.
Malberti F; Surian M; Cosci P
Nephrol Dial Transplant; 1992; 7(8):822-8. PubMed ID: 1325615
[TBL] [Abstract][Full Text] [Related]
4. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
[TBL] [Abstract][Full Text] [Related]
5. 'Pulse' oral calcitriol in uraemic patients: rapid modification of parathyroid response to calcium.
Kwan JT; Almond MK; Beer JC; Noonan K; Evans SJ; Cunningham J
Nephrol Dial Transplant; 1992; 7(8):829-34. PubMed ID: 1325616
[TBL] [Abstract][Full Text] [Related]
6. Improvement of secondary hyperparathyroidism and reduction of the set point of calcium after intravenous calcitriol.
Malberti F; Surian M; Cosci P
Kidney Int Suppl; 1993 Jun; 41():S125-30. PubMed ID: 8320905
[TBL] [Abstract][Full Text] [Related]
7. Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients.
Liou HH; Chiang SS; Huang TP; Shieh SD; Akmal M
Miner Electrolyte Metab; 1994; 20(3):97-102. PubMed ID: 7816008
[TBL] [Abstract][Full Text] [Related]
8. [Low dosage intravenous calcitriol bolus therapy in chronic hemodialysis patients].
Neyer U; Wöss E; Drexel H
Acta Med Austriaca; 1994; 21(5):129-32. PubMed ID: 7709710
[TBL] [Abstract][Full Text] [Related]
9. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.
Fischer ER; Harris DC
Clin Nephrol; 1993 Oct; 40(4):216-20. PubMed ID: 8261678
[TBL] [Abstract][Full Text] [Related]
11. Intravenous calcitriol lowers serum calcium concentrations in uraemic patients with severe hyperparathyroidism and hypercalcaemia.
Hamdy NA; Brown CB; Kanis JA
Nephrol Dial Transplant; 1989; 4(6):545-8. PubMed ID: 2507976
[TBL] [Abstract][Full Text] [Related]
12. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
13. High-dose oral calcitriol and zero calcium peritoneal solutions in CAPD patients with refractory secondary hyperparathyroidism.
Malberti F; Scanziani R; Corradi B; Dozio B; Bonforte G; Imbasciati E; Surian M
Nephrol Dial Transplant; 1994; 9(12):1813-5. PubMed ID: 7708273
[TBL] [Abstract][Full Text] [Related]
14. A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients.
Peng SJ; Yang CS; Ferng SH; Chen LY
Miner Electrolyte Metab; 1997; 23(1):13-8. PubMed ID: 9058364
[TBL] [Abstract][Full Text] [Related]
15. Pulse intravenous calcitriol therapy of secondary hyperparathyroidism in peritoneal dialysis patients.
Wadhwa NK; Suh H; Howell N; Cabralda T; Sokunbi D; Solomon M
Adv Perit Dial; 1993; 9():260-3. PubMed ID: 8105939
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
[TBL] [Abstract][Full Text] [Related]
18. Evidence for both abnormal set point of PTH stimulation by calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Rodriguez AP; Felsenfeld AJ
J Bone Miner Res; 1997 Mar; 12(3):347-55. PubMed ID: 9076577
[TBL] [Abstract][Full Text] [Related]
19. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
[TBL] [Abstract][Full Text] [Related]
20. [Pulsed doses of calcitriol in the treatment of secondary hyperparathyroidism in patients on hemodialysis].
Sotorník I; Petrásek R; Schück O; Adamec M; Smrcková I; Tocík J
Vnitr Lek; 1997 Sep; 43(9):584-91. PubMed ID: 9750467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
